P B Johansen
Overview
Explore the profile of P B Johansen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
434
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bloem E, Karpf D, Norby P, Johansen P, Loftager M, Rahbek-Nielsen H, et al.
J Thromb Haemost
. 2018 Dec;
17(2):350-360.
PMID: 30525289
Essentials Factor (F)VIII with an intermediate-length B-domain showed higher levels in murine gene therapy. FVIII with different B-domain lengths were analysed. FVIII variants with B-domains between 186 and 240 amino...
2.
Rode F, Almholt K, Petersen M, Kreilgaard M, Kjalke M, Karpf D, et al.
J Thromb Haemost
. 2018 Mar;
16(6):1141-1152.
PMID: 29582559
Summary: Background N8-GP is an extended half-life recombinant factor VIII (FVIII) for the treatment of hemophilia A. Subcutaneous administration of FVIII may reduce the treatment burden of prophylaxis; however, standard...
3.
Frederiksen A, Abrahamsen B, Johansen P, Sorensen H
Osteoporos Int
. 2017 Oct;
29(1):109-114.
PMID: 28965215
Introduction: The purpose of this study was to examine the prevalence of prior major osteoporotic fractures (MOF) in the prior 10 years preceding hip fracture in order to provide information...
4.
Johansen P, Tranholm M, Haaning J, Knudsen T
Haemophilia
. 2016 Mar;
22(4):625-31.
PMID: 26936336
Introduction: The tail tip bleeding model and the tail vein transection survival model in mice are important tools for assessment of in vivo effect in haemostasis research. While the tail...
5.
Lauritzen B, Hedner U, Johansen P, Tranholm M, Ezban M
J Thromb Haemost
. 2008 Mar;
6(5):804-11.
PMID: 18315554
Background: Heparin and low molecular weight heparin (LMWH) are widely used for prevention and treatment of thromboemobolic events, but may occasionally cause uncontrollable bleeding. Heparin can readily be antagonized with...
6.
Malmlof K, Zaragoza F, Golozoubova V, Refsgaard H, Cremers T, Raun K, et al.
Int J Obes (Lond)
. 2005 Sep;
29(12):1402-12.
PMID: 16151415
Objective: This study was conducted to elucidate whether antagonistic targeting of the histamine H3 receptor increases hypothalamic histamine levels, in parallel with decreases in food intake and body weight. Methods:...
7.
Holm A, Johansen P, Ahnfelt-Ronne I, Romer J
Eur J Endocrinol
. 2004 Jun;
150(6):893-904.
PMID: 15191361
Objective: The aim was to investigate the possible interactions of the two peripheral hormones, leptin and ghrelin, that regulate the energy balance in opposite directions. Methods: Leptin-receptor mutated Zucker diabetic...
8.
Gelling R, Du X, Dichmann D, Romer J, Huang H, Cui L, et al.
Proc Natl Acad Sci U S A
. 2003 Jan;
100(3):1438-43.
PMID: 12552113
Glucagon, the counter-regulatory hormone to insulin, is secreted from pancreatic alpha cells in response to low blood glucose. To examine the role of glucagon in glucose homeostasis, mice were generated...
9.
Malmlof K, Bauer M, Johansen P, Ankersen M, Veldhuis J
Endocrine
. 2002 Apr;
16(3):195-9.
PMID: 11954663
Repeated administration of growth hormone secretagogues (GHSs) has proven to be a delicate matter owing to development of tolerance. The aim of the present study was to define conditions during...
10.
ANDERSEN N, Malmlof K, Johansen P, Andreassen T, Ortoft G, Oxlund H
Growth Horm IGF Res
. 2001 Dec;
11(5):266-72.
PMID: 11735244
The ability of the growth hormone secretagogue (GHS) Ipamorelin to counteract the catabolic effects of glucocorticoid (GC) on skeletal muscles and bone was investigated in vivo in an adult rat...